The outcomes of allogeneic stem cell transplantation in AML patients with monosomal karyotypes

被引:0
|
作者
Sohn, S. K. [1 ]
Moon, J. H. [1 ]
Lee, Y. J. [1 ]
Lee, S. J. [1 ]
Do, Y. R. [2 ]
Kim, Y. K. [1 ]
Suh, J. S. [1 ]
机构
[1] Kyungpook Natl Univ Hosp, Taegu, South Korea
[2] Keimyung Univ, Dongsan Hosp, Taegu, South Korea
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S99 / S100
页数:2
相关论文
共 50 条
  • [21] Impact of Remission Status on Outcomes in AML Patients ≥ 60 Years of Age after Allogeneic Stem Cell Transplantation
    Bhamidipati, Pavan
    Han, Young Se
    DiPersio, John F.
    Stockerl-Goldstein, Keith E.
    Liu, Jingxia
    Uy, Geoffrey L.
    Westervelt, Peter
    Vij, Ravi
    Schroeder, Mark A.
    Abboud, Camille N.
    Cashen, Amanda F.
    Bagegni, Nusayba A.
    Romee, Rizwan
    BLOOD, 2014, 124 (21)
  • [22] OUTCOMES OF PATIENTS RELAPSING FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION FOR AML IN FIRST CR: SINGLE CENTER EXPERIENCE
    Pastore, D.
    Carluccio, P.
    Delia, M.
    Ricco, A.
    Rossi, A. Russo
    De Candia, M. S.
    Mestice, A.
    Carluccio, V.
    Gagliardi, V. P.
    D'Agostino, S.
    Pasciolla, C.
    Albano, F.
    Specchia, G.
    HAEMATOLOGICA, 2017, 102 : 635 - 636
  • [23] Monosomal karyotype affecting outcomes of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission
    Choi, Yunsuk
    Lee, Je-Hwan
    Lee, Jung-Hee
    Park, Han-Seung
    Choi, Eun-Ji
    Jo, Jae-Cheol
    Lee, Yoo Jin
    Lee, Young-Shin
    Kang, Young-Ah
    Lee, Kyoo-Hyung
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 105 (03) : 262 - 273
  • [24] Busulfan Does Intensity and Outcomes in Reduced Intensity Allogeneic Stem Cell Transplantation for MDS/AML
    Chen, Yi-Bin
    Coughlin, Erin
    Cutler, Corey
    Kennedy, Kevin
    Alyea, Edwin P., III
    Armand, Philippe
    Attar, Eyal C.
    Ballen, Karen
    Dey, Bimalangshu R.
    Koreth, John
    McAfee, Steven L.
    Spitzer, Thomas R.
    Antin, Joseph H.
    Soiffer, Robert J.
    Ho, Vincent T.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S114 - S115
  • [25] ELN risk stratification and outcomes in secondary and therapy-related AML patients consolidated with allogeneic stem cell transplantation
    Jentzsch, Madlen
    Grimm, Juliane
    Bill, Marius
    Brauer, Dominic
    Backhaus, Donata
    Goldmann, Karoline
    Schulz, Julia
    Niederwieser, Dietger
    Platzbecker, Uwe
    Schwind, Sebastian
    BONE MARROW TRANSPLANTATION, 2021, 56 (04) : 936 - 945
  • [26] GATA2-Mutated AML: Clinical Outcomes and Spectrum of Infections in Patients Undergoing or Not Allogeneic Stem Cell Transplantation
    Sanchez-Petitto, Gabriela
    El Boghdadly, Zeinab
    Nicolet, Deedra
    Cooper, Julia
    Eisfeld, Ann-Kathrin
    Klein, Victoria
    Walker, Michael C.
    Mrozek, Krzysztof
    Bezerra, Evandro
    Brammer, Jonathan E.
    Denlinger, Nathan
    Shindiapina, Polina
    Penza, Sam
    Wall, Sarah A.
    Behbehani, Gregory K.
    Blachly, James S.
    Blaser, Bradley Wayne
    Borate, Uma
    Grieselhuber, Nicole R.
    Koenig, Kristin L.
    Larkin, Karilyn T.
    Long, Meixiao
    Mims, Alice
    Srisuwananukorn, Andrew
    Vasu, Sumithira
    de Lima, Marcos
    BLOOD, 2024, 144 : 7309 - 7310
  • [27] Tailored strategy for AML patients receiving allogeneic peripheral blood stem cell transplantation
    Sohn, Sang Kyun
    Kim, Jong Gwang
    Kim, Dong Hwan
    JOURNAL OF CLINICAL APHERESIS, 2006, 21 (03) : 207 - 213
  • [28] ELN risk stratification and outcomes in secondary and therapy-related AML patients consolidated with allogeneic stem cell transplantation
    Madlen Jentzsch
    Juliane Grimm
    Marius Bill
    Dominic Brauer
    Donata Backhaus
    Karoline Goldmann
    Julia Schulz
    Dietger Niederwieser
    Uwe Platzbecker
    Sebastian Schwind
    Bone Marrow Transplantation, 2021, 56 : 936 - 945
  • [29] Monosomal Karyotype at the Time of Diagnosis or Transplantation Predicts Outcomes of Allogeneic Hematopoietic Cell Transplantation in Myelodysplastic Syndrome
    Ustun, Celalettin
    Trottier, Bryan J.
    Sachs, Zohar
    DeFor, Todd E.
    Shune, Leyla
    Courville, Elizabeth L.
    Holtan, Shernan G.
    Dolan, Michelle
    Weisdorf, Daniel J.
    Warlick, Erica D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (05) : 866 - 872
  • [30] DNMT3A mutation in AML patients after allogeneic stem cell transplantation
    Blau, O.
    Berenstein, R.
    Nogai, A.
    Rieger, K.
    Hemmati, P.
    Jehn, C.
    Doerken, B.
    Arnold, R.
    Blau, I. W.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S60 - S60